MMP17
MMP17, also known as MT4-MMP, is a membrane-type matrix metalloproteinase that degrades extracellular matrix components such as fibrin. It is unusual among its subfamily in being anchored to the cell surface by a glycosylphosphatidylinositol (GPI) anchor. Browse Assay Genie's current range of MMP17 research reagents below, or read on for the biology behind the target.
MMP17 is an endopeptidase that degrades various components of the extracellular matrix, including fibrin. It may also be involved in activating membrane-bound precursors of growth factors or inflammatory mediators, such as tumour necrosis factor-alpha. It cleaves pro-TNF at the 74-Ala-|-Gln-75 site. Whether it can proteolytically activate progelatinase A is not clear. It does not hydrolyse collagen types I, II, III, IV or V, gelatin, fibronectin, laminin, decorin or alpha1-antitrypsin, which sets its substrate profile apart from many other matrix metalloproteinases.
The MMP17 gene encodes a member of the peptidase M10 family and the membrane-type subfamily of matrix metalloproteinases (MMPs); UniProt places the protein in the peptidase M10A family, and HGNC lists it in the M10 matrix metallopeptidases group. Membrane-type members carry a transmembrane domain and are expressed at the cell surface rather than secreted. MMP17 is the exception, as it is anchored to the cell membrane through a GPI anchor. The encoded preproprotein is proteolytically processed to give the mature protease. UniProt records it at the cell membrane and in the extracellular matrix.
MMPs as a group contribute to extracellular matrix breakdown in normal processes such as embryonic development, reproduction and tissue remodelling, and in disease processes such as arthritis and metastasis. Elevated expression of MMP17 has been observed in osteoarthritis and in multiple human cancers, and the protein may be involved in tumoral processes. HGNC lists earlier names that include matrix metalloproteinase 17 (membrane-inserted), and MT4-MMP is the common alias. A mouse ortholog, Mmp17, is recognised.
Elevated MMP17 expression has been observed in multiple human cancers, and the protease may be involved in tumoral processes.
Increased expression of MMP17 has been reported in osteoarthritis, making it relevant to studies of joint tissue breakdown.
As a matrix endopeptidase that degrades components such as fibrin, MMP17 is relevant to tissue remodelling and development.
MMP17 cleaves pro-TNF at the 74-Ala-|-Gln-75 site, linking it to activation of inflammatory mediator precursors.
MMP17 is a membrane-anchored endopeptidase that degrades extracellular matrix components such as fibrin. It may help activate membrane-bound precursors of growth factors or inflammatory mediators, and it cleaves pro-TNF at the 74-Ala-|-Gln-75 site. It may also be involved in tumoral processes.
Yes. MT4-MMP is an alias of MMP17, reflecting its place in the membrane-type MMP subfamily. HGNC also records the earlier names matrix metalloproteinase 17 (membrane-inserted) and matrix metallopeptidase 17 (membrane-inserted). The official name is matrix metallopeptidase 17.
Unlike other membrane-type MMPs, MMP17 is anchored to the cell membrane by a GPI anchor. Elevated expression has been observed in osteoarthritis and multiple human cancers. A mouse ortholog, Mmp17, exists; check the datasheet of any product for its validated reactivity.
Other membrane-type matrix metalloproteinases and MMP family members, including collagenases, gelatinases and stromelysins, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9ULZ9; product specifications from Assay Genie datasheets.